Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00508885 · ClinicalTrials.gov registry record · Phase 1
The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients
A Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT00508885 is a Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 17 participants.
The verdict
NCT00508885, a Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
Hyperphosphatemia is common in the peritoneal dialysis population. Current strategies are insufficient to optimize phosphorus control. Animal studies have shown niacinamide, a form of vitamin B, to reduce phosphate uptake by the rat small intestine. Our trial investigates the use of niacinamide, in addition to standard phosphorus lowering strategies, to reduce plasma phosphorus levels in peritoneal dialysis patients versus placebo.
Interventions
- DRUG Placebo
- DRUG Niacinamide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2006-10 |
| Est. Completion | 2007-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00508885
The ClinicalTrials.gov registry entry for NCT00508885 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00508885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00508885 about?
NCT00508885 is a clinical study titled "The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients". Hyperphosphatemia is common in the peritoneal dialysis population. Current strategies are insufficient to optimize phosphorus control. Animal studies have shown niacinamide, a form of vitamin B, to reduce phosphate uptake by the rat small intestine. Our trial investigates the use of niacinamide, in ...
What is the current status of trial NCT00508885?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2006-10. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00508885?
The interventions under investigation include: Placebo (DRUG), Niacinamide (DRUG).
Who is sponsoring clinical trial NCT00508885?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.